ClinConnect ClinConnect Logo
Search / Trial NCT02166216

The North Sea Race Endurance Exercise Study

Launched by HELSE STAVANGER HF · Jun 15, 2014

Trial Information

Current as of July 21, 2025

Active, not recruiting

Keywords

Prolonged High Intensity Exercise Healthy Subjects Cardiovascular Risk Markers Troponin Leisure Sports Athletes Cycling Ct Coronary Angiography Outcomes

ClinConnect Summary

The North Sea Race Endurance Exercise Study is looking at how intense exercise, like a long cycling race, affects heart health in healthy athletes. Specifically, the study focuses on measuring levels of a protein called cardiac troponin I (cTnI), which can indicate heart damage after strenuous exercise. Researchers want to understand if higher levels of this protein are linked to heart disease and other heart-related issues in people who participate in a 91-kilometer cycling competition.

To join the study, participants should be healthy individuals who are signed up for the North Sea Race and have completed an online questionnaire before the event. Unfortunately, those with heart disease, high blood pressure, diabetes, or those on heart medications cannot participate. While the trial is currently active, they are not recruiting new participants at this time. This study will help clarify the impact of high-intensity exercise on heart health and may provide important insights for athletes and health professionals alike.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • participants in the "North sea race"
  • presumably healthy persons
  • signed informed consent
  • answered internet based questionnaire prior to the race
  • Exclusion Criteria:
  • cardiac disease
  • hypertension
  • diabetes mellitus
  • use of primary cardiovascular medical prevention

About Helse Stavanger Hf

Helse Stavanger HF is a leading healthcare organization based in Norway, dedicated to providing high-quality medical services and advancing clinical research. As a prominent sponsor of clinical trials, Helse Stavanger HF focuses on innovative therapeutic interventions across various medical fields, aiming to enhance patient care and outcomes. With a commitment to ethical research practices and collaboration with academic institutions, the organization plays a vital role in the development of new treatments and the improvement of healthcare standards in the region and beyond.

Locations

Stavanger, , Norway

Patients applied

0 patients applied

Trial Officials

Stein Ørn, MD PhD

Principal Investigator

Helse Stavanger HF

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials